Effects of the lipid environment, cholesterol and bile acids on the function of the purified and reconstituted human ABCG2 protein

Biochemical Journal

Volumn 450, Issue 2, 2013, Pages 387-395

  Telbisz, Agnes ^a   Ozvegy Laczka, Csilla ^b   Hegedus, Tamas ^b,c   Varadi, Andras ^d   Sarkadi, Balazs ^a,b,c  

^a INSTITUTE OF MATERIALS AND ENVIRONMENTAL CHEMISTRY   (Hungary)

^b National Blood Service   (Hungary)

^c SEMMELWEIS UNIVERSITY   (Hungary)

^d INSTITUTE OF EXPERIMENTAL MEDICINE   (Hungary)

Author keywords

ABCG2; Bile acid; Cholesterol; Multidrug resistance

Indexed keywords

ADENOSINE TRIPHOSPHATASE; BILE ACID; BREAST CANCER RESISTANCE PROTEIN; CHOLESTEROL; DIMER; LIPID;

ARTICLE; CELL MEMBRANE; CONTROLLED STUDY; ENZYME ACTIVITY; MOLECULAR MECHANICS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN TRANSPORT; SOLUBILIZATION; WILD TYPE;

ADENOSINE TRIPHOSPHATASES; ATP-BINDING CASSETTE TRANSPORTERS; BILE ACIDS AND SALTS; BIOLOGICAL TRANSPORT, ACTIVE; CELL LINE; CELL MEMBRANE; CHOLESTEROL; HUMANS; MEMBRANE LIPIDS; NEOPLASM PROTEINS; SF9 CELLS;

EID: 84874080809     PISSN: 02646021     EISSN: 14708728     Source Type: Journal    
DOI: 10.1042/BJ20121485     Document Type: Article

References (41)

1. Sarkadi, B., Homolya, L., Szakacs, G. and Varadi, A. (2006) Human multidrug resistance ABCB and ABCG transporters: participation in a chemoimmunity defense system. Physiol. Rev. 86, 1179-1236
2. Robey, R. W., Massey, P. R., Amiri-Kordestani, L. and Bates, S. E. (2010) ABC transporters: unvalidated therapeutic targets in cancer and the CNS. Anti-Cancer Agents Med. Chem. 10, 625-633
3. Jacobs, A., Emmert, D., Wieschrath, S., Hrycyna, C. A. and Wiese, M. (2011) Recombinant synthesis of human ABCG2 expressed in the yeast Saccharomyces cerevisiae: an experimental methodological study. Protein J. 30, 201-211
4. McDevitt, C. A., Collins, R. F., Conway, M., Modok, S., Storm, J., Kerr, I. D., Ford, R. C. and Callaghan, R. (2006) Purification and 3D structural analysis of oligomeric human multidrug transporter ABCG2. Structure 14, 1623-1632
5. Pozza, A., Perez-Victoria, J. M., Sardo, A., Ahmed-Belkacem, A. and Di Pietro, A. (2006) Purification of breast cancer resistance protein ABCG2 and role of arginine-482. Cell. Mol. Life Sci. 63, 1912-1922
6. Pal, A., Mehn, D., Molnar, E., Gedey, S., Meszaros, P., Nagy, T., Glavinas, H., Janaky, T., von Richter, O., Bathori, G. et al. (2007) Cholesterol potentiates ABCG2 activity in a heterologous expression system: improved in vitro model to study function of human ABCG2. J. Pharmacol. Exp. Ther. 321, 1085-1094
7. Storch, C. H., Ehehalt, R., Haefeli, W. E. and Weiss, J. (2007) Localization of the human breast cancer resistance protein (BCRP/ABCG2) in lipid rafts/caveolae and modulation of its activity by cholesterol in vitro. J. Pharmacol. Exp. Ther. 323, 257-264
8. Telbisz, A., Muller, M., Ozvegy-Laczka, C., Homolya, L., Szente, L., Varadi, A. and Sarkadi, B. (2007) Membrane cholesterol selectively modulates the activity of the human ABCG2 multidrug transporter. Biochim. Biophys. Acta 1768, 2698-2713
9. Ozvegy, C., Varadi, A. and Sarkadi, B. (2002) Characterization of drug transport, ATP hydrolysis, and nucleotide trapping by the human ABCG2 multidrug transporter. Modulation of substrate specificity by a point mutation. J. Biol. Chem. 277, 47980-47990
10. Ozvegy, C., Litman, T., Szakacs, G., Nagy, Z., Bates, S., Varadi, A. and Sarkadi, B. (2001) Functional characterization of the human multidrug transporter, ABCG2, expressed in insect cells. Biochem. Biophys. Res. Commun. 285, 111-117
11. Sarkadi, B., Price, E. M., Boucher, R. C., Germann, U. A. and Scarborough, G. A. (1992) Expression of the human multidrug resistance cDNA in insect cells generates a high activity drug-stimulated membrane ATPase. J. Biol. Chem. 267, 4854-4858
12. Ozvegy-Laczka, C., Laczko, R., Hegedus, C., Litman, T., Varady, G., Goda, K., Hegedus, T., Dokholyan, N. V., Sorrentino, B. P., Varadi, A. and Sarkadi, B. (2008) Interaction with the 5D3 monoclonal antibody is regulated by intramolecular rearrangements but not by covalent dimer formation of the human ABCG2 multidrug transporter. J. Biol. Chem. 283, 26059-26070
13. Ozvegy-Laczka, C., Koblos, G., Sarkadi, B. and Varadi, A. (2005) Single amino acid (482) variants of the ABCG2 multidrug transporter: major differences in transport capacity and substrate recognition. Biochim. Biophys. Acta 1668, 53-63
14. Urbatsch, I. L. and Senior, A. E. (1995) Effects of lipids on ATPase activity of purified Chinese hamster P-glycoprotein. Arch. Biochem. Biophys. 316, 135-140
15. Kage, K., Tsukahara, S., Sugiyama, T., Asada, S., Ishikawa, E., Tsuruo, T. and Sugimoto, Y. (2002) Dominant-negative inhibition of breast cancer resistance protein as drug efflux pump through the inhibition of S-S dependent homodimerization. Int. J. Cancer 97, 626-630
16. Hegedus, C., Ozvegy-Laczka, C., Apati, A., Magocsi, M., Nemet, K., Orfi, L., Keri, G., Katona, M., Takats, Z., Varadi, A. et al. (2009) Interaction of nilotinib, dasatinib and bosutinib with ABCB1 and ABCG2: implications for altered anti-cancer effects and pharmacological properties. Br. J. Pharmacol. 158, 1153-1164
17. Sesink, A. L., Arts, I. C., de Boer, V. C., Breedveld, P., Schellens, J. H., Hollman, P. C. and Russel, F. G. (2005) Breast cancer resistance protein (Bcrp1/Abcg2) limits net intestinal uptake of quercetin in rats by facilitating apical efflux of glucuronides. Mol. Pharmacol. 67, 1999-2006
18. Allen, J. D., van Loevezijn, A., Lakhai, J. M., van der Valk, M., van Tellingen, O., Reid, G., Schellens, J. H., Koomen, G. J. and Schinkel, A. H. (2002) Potent and specific inhibition of the breast cancer resistance protein multidrug transporter in vitro and in mouse intestine by a novel analogue of fumitremorgin C. Mol. Cancer Ther. 1, 417-425
19. Ozvegy-Laczka, C., Varady, G., Koblos, G., Ujhelly, O., Cervenak, J., Schuetz, J. D., Sorrentino, B. P., Koomen, G. J., Varadi, A., Nemet, K. and Sarkadi, B. (2005) Function-dependent conformational changes of the ABCG2 multidrug transporter modify its interaction with a monoclonal antibody on the cell surface. J. Biol. Chem. 280, 4219-4227
20. Ejendal, K. F., Diop, N. K., Schweiger, L. C. and Hrycyna, C. A. (2006) The nature of amino acid 482 of human ABCG2 affects substrate transport and ATP hydrolysis but not substrate binding. Protein Sci. 15, 1597-1607
21. Telbisz, A., Hegedus, C., Ozvegy-Laczka, C., Goda, K., Varady, G., Takats, Z., Szabo, E., Sorrentino, B. P., Varadi, A. and Sarkadi, B. (2011) Antibody binding shift assay for rapid screening of drug interactions with the human ABCG2 multidrug transporter. Eur. J. Pharm. Sci. 45, 101-109
22. Galian, C., Manon, F., Dezi, M., Torres, C., Ebel, C., Levy, D. and Jault, J. M. (2011) Optimized purification of a heterodimeric ABC transporter in a highly stable form amenable to 2-D crystallization. PLoS ONE 6, e19677
23. Herget, M., Kreissig, N., Kolbe, C., Scholz, C., Tampe, R. and Abele, R. (2009) Purification and reconstitution of the antigen transport complex TAP: a prerequisite for determination of peptide stoichiometry and ATP hydrolysis. J. Biol. Chem. 284, 33740-33749
24. Shapiro, A. B. and Ling, V. (1994) ATPase activity of purified and reconstituted P-glycoprotein from Chinese hamster ovary cells. J. Biol. Chem. 269, 3745-3754
25. al-Shawi, M. K. and Senior, A. E. (1993) Characterization of the adenosine triphosphatase activity of Chinese hamster P-glycoprotein. J. Biol. Chem. 268, 4197-4206
26. Ambudkar, S. V., Lelong, I. H., Zhang, J., Cardarelli, C. O., Gottesman, M. M. and Pastan, I. (1992) Partial purification and reconstitution of the human multidrug-resistance pump: characterization of the drug-stimulatable ATP hydrolysis. Proc. Natl. Acad. Sci. U.S.A. 89, 8472-8476
27. Jones, P. M. and George, A. M. (2004) The ABC transporter structure and mechanism: perspectives on recent research. Cell. Mol. Life Sci. 61, 682-699
28. Locher, K. P. (2004) Structure and mechanism of ABC transporters. Curr. Opin. Struct. Biol. 14, 426-431
29. Homolya, L., Orban, T. I., Csanady, L. and Sarkadi, B. (2011) Mitoxantrone is expelled by the ABCG2 multidrug transporter directly from the plasma membrane. Biochim. Biophys. Acta 1808, 154-163
30. Blazquez, A. G., Briz, O., Romero, M. R., Rosales, R., Monte, M. J., Vaquero, J., Macias, R. I., Cassio, D. and Marin, J. J. (2011) Characterization of the role of ABCG2 as a bile acid transporter in liver and placenta. Mol. Pharmacol. 81, 273-283
31. Bucher, K., Belli, S., Wunderli-Allenspach, H. and Kramer, S. D. (2007) P-glycoprotein in proteoliposomes with low residual detergent: the effects of cholesterol. Pharm. Res. 24, 1993-2004
32. Doige, C. A., Yu, X. and Sharom, F. J. (1993) The effects of lipids and detergents on ATPase-active P-glycoprotein. Biochim. Biophys. Acta 1146, 65-72
33. Eckford, P. D. and Sharom, F. J. (2005) The reconstituted P-glycoprotein multidrug transporter is a flippase for glucosylceramide and other simple glycosphingolipids. Biochem. J. 389, 517-526
34. Eckford, P. D. and Sharom, F. J. (2008) Interaction of the P-glycoprotein multidrug efflux pump with cholesterol: effects on ATPase activity, drug binding and transport. Biochemistry 47, 13686-13698
35. Garrigues, A., Escargueil, A. E. and Orlowski, S. (2002) The multidrug transporter, P-glycoprotein, actively mediates cholesterol redistribution in the cell membrane. Proc. Natl. Acad. Sci. U.S.A. 99, 10347-10352
36. Belli, S., Elsener, P. M., Wunderli-Allenspach, H. and Kramer, S. D. (2009) Cholesterol-mediated activation of P-glycoprotein: distinct effects on basal and drug-induced ATPase activities. J. Pharm. Sci. 98, 1905-1918
37. Rothnie, A., Theron, D., Soceneantu, L., Martin, C., Traikia, M., Berridge, G., Higgins, C. F., Devaux, P. F. and Callaghan, R. (2001) The importance of cholesterol in maintenance of P-glycoprotein activity and its membrane perturbing influence. Eur. Biophys. J. 30, 430-442
38. Ozvegy-Laczka, C., Cserepes, J., Elkind, N. B. and Sarkadi, B. (2005) Tyrosine kinase inhibitor resistance in cancer: role of ABC multidrug transporters. Drug Resist. Updates 8, 15-26
39. Al-Shawi, M. K., Polar, M. K., Omote, H. and Figler, R. A. (2003) Transition state analysis of the coupling of drug transport to ATP hydrolysis by P-glycoprotein. J. Biol. Chem. 278, 52629-52640
40. Ernst, R., Kueppers, P., Stindt, J., Kuchler, K. and Schmitt, L. (2010) Multidrug efflux pumps: substrate selection in ATP-binding cassette multidrug efflux pumps: first come, first served? FEBS J. 277, 540-549
41. Krupka, R. M. (1999) Uncoupled active transport mechanisms accounting for low selectivity in multidrug carriers: P-glycoprotein and SMR antiporters. J. Membr. Biol. 172, 129-143